Yamamoto M - Search Results

1

Protective immunity to Streptococcus mutans induced by nasal vaccination with surface protein antigen and mutant cholera toxin adjuvant.

Saito M, Otake S, Ohmura M, Hirasawa M, Takada K, Mega J, Takahashi I, Kiyono H, McGhee JR, Takeda Y, Yamamoto M. Saito M, et al. Among authors: yamamoto m. J Infect Dis. 2001 Mar 1;183(5):823-6. doi: 10.1086/318826. Epub 2001 Jan 29. J Infect Dis. 2001. PMID: 11181162

2

Nasal immunization induces Haemophilus influenzae-specific Th1 and Th2 responses with mucosal IgA and systemic IgG antibodies for protective immunity.

Kurono Y, Yamamoto M, Fujihashi K, Kodama S, Suzuki M, Mogi G, McGhee JR, Kiyono H. Kurono Y, et al. Among authors: yamamoto m. J Infect Dis. 1999 Jul;180(1):122-32. doi: 10.1086/314827. J Infect Dis. 1999. PMID: 10353870

3

Direct effects on antigen-presenting cells and T lymphocytes explain the adjuvanticity of a nontoxic cholera toxin mutant.

Yamamoto M, Kiyono H, Yamamoto S, Batanero E, Kweon MN, Otake S, Azuma M, Takeda Y, McGhee JR. Yamamoto M, et al. Among authors: yamamoto s. J Immunol. 1999 Jun 15;162(12):7015-21. J Immunol. 1999. PMID: 10358143

4

Enterotoxin adjuvants have direct effects on T cells and antigen-presenting cells that result in either interleukin-4-dependent or -independent immune responses.

Yamamoto M, Kiyono H, Kweon MN, Yamamoto S, Fujihashi K, Kurazono H, Imaoka K, Bluethmann H, Takahashi I, Takeda Y, Azuma M, McGhee JR. Yamamoto M, et al. Among authors: yamamoto s. J Infect Dis. 2000 Jul;182(1):180-90. doi: 10.1086/315694. Epub 2000 Jun 30. J Infect Dis. 2000. PMID: 10882596

5

Genetically manipulated bacterial toxin as a new generation mucosal adjuvant.

Yamamoto M, McGhee JR, Hagiwara Y, Otake S, Kiyono H. Yamamoto M, et al. Scand J Immunol. 2001 Mar;53(3):211-7. doi: 10.1046/j.1365-3083.2001.00883.x. Scand J Immunol. 2001. PMID: 11251876 Free article. Review.

6

Highly purified mutant E112K of cholera toxin elicits protective lung mucosal immunity to diphtheria toxin.

Ohmura M, Yamamoto M, Kiyono H, Fujihashi K, Takeda Y, McGhee JR. Ohmura M, et al. Among authors: yamamoto m. Vaccine. 2001 Dec 12;20(5-6):756-62. doi: 10.1016/s0264-410x(01)00412-1. Vaccine. 2001. PMID: 11738739

7

Effects of intranasal immunization on protective immunity against otitis media.

Kurono Y, Suzuki M, Mogi G, Yamamoto M, Fujihashi K, McGhee JR, Kiyono H. Kurono Y, et al. Among authors: yamamoto m. Int J Pediatr Otorhinolaryngol. 1999 Oct 5;49 Suppl 1:S227-9. doi: 10.1016/s0165-5876(99)00165-2. Int J Pediatr Otorhinolaryngol. 1999. PMID: 10577810

8

Alternate mucosal immune system: organized Peyer's patches are not required for IgA responses in the gastrointestinal tract.

Yamamoto M, Rennert P, McGhee JR, Kweon MN, Yamamoto S, Dohi T, Otake S, Bluethmann H, Fujihashi K, Kiyono H. Yamamoto M, et al. Among authors: yamamoto s. J Immunol. 2000 May 15;164(10):5184-91. doi: 10.4049/jimmunol.164.10.5184. J Immunol. 2000. PMID: 10799877

9

M cell-targeted mucosal vaccine strategies.

Yamamoto M, Pascual DW, Kiyono H. Yamamoto M, et al. Curr Top Microbiol Immunol. 2012;354:39-52. doi: 10.1007/82_2011_134. Curr Top Microbiol Immunol. 2012. PMID: 21688209 Free PMC article. Review.

10

Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection.

Yamamoto M, McDaniel LS, Kawabata K, Briles DE, Jackson RJ, McGhee JR, Kiyono H. Yamamoto M, et al. Infect Immun. 1997 Feb;65(2):640-4. doi: 10.1128/iai.65.2.640-644.1997. Infect Immun. 1997. PMID: 9009325 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,384 results

Search Page

Filters